Menu ×


Cancer Services Market : Global Demand Analysis, Growth & Opportunity Outlook 2023

  • Report ID: 227
  • Text Size:

Extensive insights into the Growth of Cancer Services Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Global Cancer Services Market Overview

Cancer is distortion in which abnormal growth of cells form group of diseases. Cancer such as tumors spreads throughout the body and may results in organ failure. Unwanted or abnormal growth of several cells in the body contributes for the dysfunction character of the organ.

The cancer services market is estimated to expand in terms of demand in near future owing to increasing number of cancer patients across the globe. Growing awareness across the globe towards the early diagnosis for cancer in order to prevent the abnormal growth of cells is driving the market of cancer services. Rapid growth in healthcare sectors owing to increasing investments in research and development aims to provide affordable and effective cancer services for prevention, treatment and post treatment. Emerging economies are adopting advanced therapies and healthcare treatments to minimize the burden of cancer which will further help the federal authorities to minimize the healthcare spending. Moreover, introduction of favorable re-imbursement policies by the government organizations across the globe are likely to emphasize patients to adopt cancer services in near future.

                                 Cancer Services Market Demand

Market size and forecast

Under global cancer services market, the cancer therapy segment is projected to expand at a CAGR of 17.2% over the forecast period i.e. 2016-2023. Moreover, the breast cancer therapy segment accounted USD 25.5 Billion in 2015, expanding at a CAGR of 14.2% during the forecast period i.e. 2016-2023.

Regionally, North America accounted the highest market share in terms of revenue in overall market of cancer services across the globe. The market of North America region is expected to continue its dominance over the forecast period i.e. 2016-2023 on the back of introduction of favorable re-imbursement policies in the region, increasing incidences of cancer and adoption of technological advanced equipment for cancer diagnostics and advanced therapies for treatment of cancer. Moreover, the North-America market of cancer services is majorly driven on account of increasing personal disposable income of the population and increasing healthcare spending of population. The cancer patients in U.S. are increasing with pace and is expected to increase by 25% of the last year diagnosed patients i.e. 14.5 Million. CLICK TO DOWNLOAD FREE SAMPLE REPORT

On the other hand, Asia-Pacific is expected to be the fastest growing and revenue generated market across the globe in near future. The market is driven by rising incidences of cancer patients and increasing awareness towards treatment and cure of cancer in Asia-pacific regions such as Japan, India, China, etc. Increasing investment in healthcare sector in order to reduce the burden of diseases in terms of human suffering is likely to grow the market of cancer services. The market of cancer services is riding on the back of governmental initiatives in the Asia-Pacific region which are creating awareness among the population regarding cancer services. However, major vaccine manufacturers are shifting towards India to increase profitability by participating in the India vaccine technology market is fostering the market of cancer services across the region.

Technological advancements in imaging sector and digitalization cancer diagnostics tests will shift the technology to a cutting-edge level of diagnosis. Characteristics such as time savings and precise diagnosis are some of the key elements for the growth of cancer services market.  Apart from this, automation of diagnostic test reduces time and cost and caters precise outputs, thus gaining trust of physicians and consumers across the globe.

Likewise, increasing awareness towards vaccinations and cancer therapeutics is increasing the demand for cancer services for prevention of life-threatening diseases. Rapid growth in geriatric population along with higher risk of cancer is shifting towards early diagnosis and preventive care services of cancer.

Market Segmentation

Our in-depth analysis segmented the global cancer services market in the following segments:

By Services

  • By Preventive Care Services

    • By Vaccines

      • Live Attenuated Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Recombinant Vector Vaccines
      • Toxoid Vaccines 
      • Synthetic Vaccines
      • Dendritic Cell Vaccines
    • By Cancer Growth Blockers

      • Tyrosine kinase inhibitors
      • Proteasome inhibitors
      • mTOR inhibitors
  • By Diagnostic Care Services

    • By Diagnostic Tests

      • Prostate-specific antigen (PSA) Tests
      • Circulating Tumor Cells (CTC) Tests
      • Alpha-fetoprotein (AFP) Tests
      • Estimated Glomerular Filtration Rate (EGFR)
      • Other Diagnostic Tests
    • By Imaging

      • MRI Scan
      • PET Scan
      • CT Scan
      • Mammography
      • Ultrasound
    • By Endoscopy

      • Bronchoscopy
      • Colonoscopy
      • Colposcopy
      • Others
    • By Biopsy
      • Bone Marrow Biopsy
      • Needle Biopsy
      • Endoscopic Biopsy
  • By Treatment Care Services

    • Hormone Therapy
    • Chemotherapy
    • Immunotherapy

By Application

  • Blood Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate Cancer

By End-User

  • Hospitals
  • Diagnostic Clinics
  • Specialty Cancer Hospitals

By Region

Global Cancer Services Market is further classified on the basis of region as follows:

  • North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Growth Drivers and challenges

The global market of cancer services is driven on the back of factors such as increase in aging population, growing awareness towards indications of cancers, shifting of patients towards cancer services for better treatment and early adoption of healthcare treatments. Additionally, increasing gross disposable income of the population which allows them to spend more on healthcare is expected to spur the demand for cancer services in near future.

Moreover, factors such as rising incidences of cancer across the globe, adoption of cancer services by the patients and increasing cases of early diagnosis in order to prevent cancer are expected to boost the market of cancer services during the forecast period i.e. 2016-2023. Likewise, government initiatives are creating awareness towards the treatment and prevention from cancer diseases. These long term initiative and increasing funding for healthcare researches are fostering the market of cancer services.

Advancement in technology in healthcare sector is helping the cancer patients to get effective and better treatment for cancer diseases. Continuous researches on cancer drugs and introduction of new and effective cancer treatment therapies are likely to foster the demand for cancer therapies globally over the forecast period i.e. 2016-2023.

Although, high cost of treatment, lack of awareness in under-developed nations, and lack of skilled healthcare physicians are some of the factors likely to hamper the market growth of cancer services market across the globe. Conversely, dearth of medical equipment and cancer treatment therapies in various undeveloped regions across the globe are hampering the growth of cancer services market. Manufacturers of cancer drugs, diagnostic equipment and various cancer treatment therapies are facing challenges in clinical trials on account of huge capital cost for research and development. Thus, high cost investment to develop effective and affordable cancer services are restraining the market of cancer services globally.

Key Players

The key players of cancer services market are as follows:

  • GE Healthcare
    • Company Overview
    • Key Product Offerings
    • Business Strategy
    • SWOT Analysis
    • Financials
  • Siemens Healthineers
  • Philips Healthcare
  • Abbott Diagnostics
  • Eli Lilly and Company
  • Novartis
  • Hoffman La-Roche Ltd.
  • Hitachi Medical Corporation
  • Hologic Inc.
  • Samsung Medison Co., Ltd. 
  • Shimadzu Corporation
  • Fonar Corporation 

Scope and Context

Overview of the Parent Market

Analyst View


The Global Cancer Services Market is segmented as follows:

  • By Preventive Care Services type Market Size and Y-O-Y Growth Analysis
  • By Diagnostics Care Services type Market Size and Y-O-Y Growth Analysis
  • By Treatment Care Services type Market Size and Y-O-Y Growth Analysis
  • By Basic Care Services type Market Size and Y-O-Y Growth Analysis
  • By End-user type Market Size and Y-O-Y Growth Analysis

By Regions

  • North America (U.S., Canada) Market Size and Y-O-Y Growth Analysis
  • Latin America (Mexico, Brazil, Rest of Latin America) Market Size and Y-O-Y Growth Analysis
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size and Y-O-Y Growth Analysis
  • Asia-Pacific (China, India, Singapore, Japan, Australia and New Zealand and Rest of Asia) Market Size and Y-O-Y Growth Analysis
  • Middle East and North Africa (MENA) Market Size and Y-O-Y Growth Analysis
  • Rest of World  Market Size and Y-O-Y Growth Analysis

Market Dynamics

Supply and Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment                 

Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved